Injected, Infused, or Implanted: A Penetrating Look At Patient Centricity

Drug Delivery Leader Chief Editor Tom von Gunden engaged drug delivery experts Beate Bittner, Shannon Hoste, Jonathan Amaya-Hodges, and Fran DeGrazio in a discussion of patient-centric considerations for delivering drugs and biologics via injection, infusion, and/or implant. The panel traced and commented on aspects of human factors and patient safety in various product development stages: formulation, device design and selection, clinical bridging, regulatory approvals, and post-market reporting.